Home » Topics » Regulatory

Regulatory
RSS

FDA approves Actonel for osteoporosis prevention and treatment

April 20, 2000

Taxol approved in Canada for adjuvant treatment of breast cancer

April 19, 2000

FDA approves Mobic for osteoarthritis symptom relief

April 18, 2000

Celecoxib: use in inflammatory conditions of the head and neck

April 18, 2000

Sanofi-Synthelabo begins rolling out Xatral XL in Europe

April 18, 2000

Enbrel recommended by FDA advisory committee for early RA

April 17, 2000

SangCya approved in Germany

April 12, 2000

Apligraf PMA supplement tentatively scheduled for FDA review in May

April 11, 2000

New formulation of Hectorol approved by FDA

April 11, 2000

Bayer obtains first approval worldwide for new antiallergic agent

April 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...